BlackRock Fund Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
NTCM
BlackRock Fund Advisors's UTMD Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Utah Medical Products (UTMD) stake by 15% in Q4 2016, buying an estimated $914K and bringing the position to 109,767 shares worth $7.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2696.
BlackRock Fund Advisors first reported a position in UTMD in Q2 2013 and has held it in 15 quarters since. 75 funds tracked by Wall St. Rank hold UTMD as of Q4 2016.
- BlackRock Fund Advisors held 109,767 shares of Utah Medical Products worth $7.99M as of Q4 2016.
- BlackRock Fund Advisors bought 14,064 Utah Medical Products shares in Q4 2016, an estimated $914K.
- Utah Medical Products made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2696 holding.
- BlackRock Fund Advisors first reported a position in Utah Medical Products in Q2 2013 and has held it in 15 quarters since.
- 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.